At the news
? MIXEDIMPACT 5/10 425 filed Oct 16, 2026 at 09:11 ET
MiMedx and Sanara each received a Second Request from the FTC on October 15, 2026, extending the HSR Act waiting period for their pending merger. The Second Request delays the close by at least 30 days after substantial compliance, introducing regulatory uncertainty but not a deal-breaker. The filing confirms both parties are cooperating with the FTC, and no deal terms have changed.
- MiMedx and Sanara each received a Second Request from the FTC on October 15, 2026.
- The Second Request extends the HSR waiting period until 30 days after substantial compliance, unless extended or terminated earlier.
- Completion of the merger remains subject to HSR clearance and other closing conditions.
- The company states it continues to work constructively with the FTC.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access